TransCode Therapeutics had a successful 2023, raising funds and advancing lead candidate, positive outlook.
From GlobeNewswire: 2024-04-03 09:10:00 TransCode Therapeutics, Inc. reported financial results for 2023, highlighting the advancement of lead therapeutic candidate TTX-MC138
